Drawing for VINHHOAN COLLAGEN5

USPTO serial 79139371

VINHHOAN COLLAGEN5

Reviewed by CopyMark Law Group

Reg. 4574131Status 709
Filing date
Status date
Registration date
Jul 29, 2014
Examiner
KOZAK, EVIN L
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VINHHOAN COLLAGEN5?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicholas D. Wells

Nicholas D. Wells Legends Law Group, PLLC330 Main St.Kaysville, UT 84037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics containing collagenSECTION 71 - CANCELLED—
005Gelatin for medical purposes, collagen protein for medical purposes; health food supplements; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for animal skincare; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for wounds; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations for the treatment of damaged skin and tissue; pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; pharmaceutical preparations for reducing sexual activity; pharmaceutical preparations for treating dandruff; pharmaceutical preparations against dry skin caused by pregnancy; pharmaceutical preparations for chloasma; pharmaceutical preparations for hydrating the skin during pregnancy; pharmaceutical preparations for pregnancy blemishes; pharmaceutical preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations to prevent stretch marks; pharmaceutical preparations to prevent swelling in the legs; each of the foregoing containing collagenSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 6, 2026C71TCANCELLED SECTION 71—
Jul 29, 2023REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 26, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 2, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Feb 18, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 18, 202171AGREGISTERED-SEC.71 ACCEPTED—
Feb 17, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 19, 2021ES71TEAS SECTION 71 RECEIVED—
Jul 29, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 8, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 23, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 23, 2014FIMPFINAL DISPOSITION PROCESSED—
Oct 29, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 29, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 13, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 13, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2014GPNXNOTIFICATION PROCESSED BY IB—
Apr 23, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 23, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 23, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 9, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 7, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 7, 2014ALIEASSIGNED TO LIE—
Mar 26, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 6, 2014RFNTREFUSAL PROCESSED BY IB—
Dec 17, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 13, 2013RFRRREFUSAL PROCESSED BY MPU—
Dec 13, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 12, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2013DOCKASSIGNED TO EXAMINER—
Dec 11, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 9, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 6, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance